Nutraceutical containing an oxygen-enabled composition
First Claim
Patent Images
1. A composition, comprising:
- a poly-oxygenated aluminum hydroxide comprising a clathrate containing oxygen gas molecules that is chlorine-free, wherein the poly-oxygenated aluminum hydroxide comprises particles each having a diameter of less than or equal to 212 μ
m; and
a nutraceutical.
1 Assignment
0 Petitions
Accused Products
Abstract
A composition of chlorine-free poly-oxygenated aluminum hydroxide that comprises a clathrate containing oxygen gas molecules and a nutraceutical. In one embodiment, the poly-oxygenated aluminum hydroxide has particles having a diameter of 212 μm or less. The nutraceutical may include one or more of a protein, vitamin, fiber, mineral and electrolytes. The composition may be in a powder or fluid form.
7 Citations
18 Claims
-
1. A composition, comprising:
-
a poly-oxygenated aluminum hydroxide comprising a clathrate containing oxygen gas molecules that is chlorine-free, wherein the poly-oxygenated aluminum hydroxide comprises particles each having a diameter of less than or equal to 212 μ
m; anda nutraceutical. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8)
-
-
9. A composition, comprising:
-
a poly-oxygenated aluminum hydroxide comprising a clathrate containing oxygen gas molecules that is chlorine-free; and a nutraceutical, wherein the poly-oxygenated aluminum hydroxide is configured to be orally delivered and absorbed through lining of a stomach and a small intestine of a mammal.
-
-
10. A composition, comprising:
-
a poly-oxygenated aluminum hydroxide comprising a clathrate containing oxygen gas molecules that is chlorine-free; and a nutraceutical, wherein the poly-oxygenated aluminum hydroxide is configured to not create an immune response of the mammal.
-
-
11. A composition, comprising:
-
a poly-oxygenated aluminum hydroxide comprising a clathrate containing oxygen gas molecules that is chlorine-free, a nutraceutical; wherein the composition comprises particles each having a diameter of less than or equal to 212 μ
m; andwherein the poly-oxygenated aluminum hydroxide is configured to be orally delivered and absorbed through lining of an esophagus and a stomach of a mammal. - View Dependent Claims (12, 13, 14, 15, 16, 17, 18)
-
Specification